Healthcare Resource Utilization for Recurrent Clostridium difficile Infection in a Large University Hospital in Houston, Texas

• Samuel L. Aitken,

  Affiliations University of Houston College of Pharmacy, Houston, Texas, United States of America, Baylor St. Luke’s Medical Center, Houston, Texas, United States of America

  ⨯
• Tiby B. Joseph,

  Affiliation Baylor St. Luke’s Medical Center, Houston, Texas, United States of America

  ⨯
• Dhara N. Shah,

  Affiliations University of Houston College of Pharmacy, Houston, Texas, United States of America, Baylor St. Luke’s Medical Center, Houston, Texas, United States of America

  ⨯
• Todd M. Lasco,

  Affiliation Baylor St. Luke’s Medical Center, Houston, Texas, United States of America

  ⨯
• Hannah R. Palmer,

  Affiliation Baylor St. Luke’s Medical Center, Houston, Texas, United States of America

  ⨯
• Herbert L. DuPont,

  Affiliations University of Houston College of Pharmacy, Houston, Texas, United States of America, Baylor St. Luke’s Medical Center, Houston, Texas, United States of America, University of Texas School of Public Health, Houston, Texas, United States of America, Baylor College of Medicine, Houston Texas, United States of America

  ⨯
• Yang Xie,

  Affiliation Merck & Co., Whitehouse Station, New Jersey, United States of America

  ⨯
• Kevin W. Garey

  * E-mail: kgarey@uh.edu

  Affiliations University of Houston College of Pharmacy, Houston, Texas, United States of America, Baylor St. Luke’s Medical Center, Houston, Texas, United States of America, University of Texas School of Public Health, Houston, Texas, United States of America

  ⨯